Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology

p53 loss before or after exposure to ionizing radiation accelerates BCC carcinogenesis in Ptch1+/- mice

Jennifer Hebert, Po-Lin So, Yefim Khaimskiy, Donna Albertson, Bing Huey and Ervin Epstein
Jennifer Hebert
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Po-Lin So
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yefim Khaimskiy
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna Albertson
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bing Huey
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ervin Epstein
Department of Dermatology, Univ. of California, San Francisco, San Francisco, CA, Comprehensive Cancer Center, Univ. of California, San Francisco, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2007
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

Abstract

4549

p53 is an important tumor suppressor that is mutated in 40-100% of basal cell carcinomas (BCCs). Since Ptch1+/- p53-/- mice all develop fatal early onset medulloblastomas, we tested the effects of p53 loss on experimental BCC formation in mice by breeding mice in which basal keratinocyte (floxed) p53 could be deleted by tamoxifen (tam)-activation of K14-Cre-ER. Ptch1+/-mice develop multiple microscopic BCCs after exposure to IR at age 8 weeks, and about 50% (depending on genetic background) of these mice develop macroscopic BCCs. Basal keratinocyte specific deletion of p53 by tam administration at age 6 weeks (2 weeks before IR) or at age 9 weeks (1 week after IR) produces rapid and equivalent acceleration of BCC carcinogenesis. Thus, keratinocyte p53 deleted mice develop multiple visible BCCs as early as age 5 months, in contrast to their IR-treated Ptch1+/-non-p53 deleted siblings, which developed one or two visible BCCs no earlier than age 10 months. Furthermore, visible BCC tumors were seen by age 9 months in Ptch1+/- p53 deleted mice even without IR treatment. CGH analysis indicated that global genome changes were similar in BCCs irrespective of keratinocyte p53 status. Cell lines could be established from BCCs from p53 deleted Ptch1+/- irrespective of whether or not IR had been given. These studies indicate (i) that p53 functions to restrain the effect of epithelial carcinogenesis AFTER repair of acute DNA damage, consistent with recent publications that have suggested a role of p53 in opposing “oncogene stress” (ii) that the mechanism of BCC acceleration by p53 loss does not involve marked changes in DNA copy number (iii) that acceleration of carcinogenesis in Ptch1+/- mice by p53 loss is not limited to the previously reported cerebellar tumors and (iv) that p53 loss plus hemizygosity for functioning PTCH1 is sufficient for the development of BCCs even without further imposed mutagenic insult.

Footnotes

  • 98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 67 (9 Supplement)
May 2007
Volume 67, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
p53 loss before or after exposure to ionizing radiation accelerates BCC carcinogenesis in Ptch1+/- mice
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
p53 loss before or after exposure to ionizing radiation accelerates BCC carcinogenesis in Ptch1+/- mice
Jennifer Hebert, Po-Lin So, Yefim Khaimskiy, Donna Albertson, Bing Huey and Ervin Epstein
Cancer Res May 1 2007 (67) (9 Supplement) 4549;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
p53 loss before or after exposure to ionizing radiation accelerates BCC carcinogenesis in Ptch1+/- mice
Jennifer Hebert, Po-Lin So, Yefim Khaimskiy, Donna Albertson, Bing Huey and Ervin Epstein
Cancer Res May 1 2007 (67) (9 Supplement) 4549;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Cellular and Molecular Biology

  • Abstract SY29-01: Functions of wild type and mutant p53
  • Abstract SY34-02: The impact of O2 availability on human cancer
  • Abstract SY19-01: Cell to cell variability in the responses of tumor cells to death ligands
Show more 3

p53 and BRCA1 Tumor Suppressors: Poster Presentations

  • Identification of novel p53-target genes and their physiological roles in tumor suppression and cellular senescence.
  • The role of Rybp in the regulation of p53
  • p53-regulated FAK expression in human tumors
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement